Banking together

During the past 10 years, human biological material—body fluids, cells, tissues, intracellular substances or Dna—and the related data have become an important resource for academic medical research, and for the industrial development of diagnostics and therapeutics (godard et al, 2003). the increasing creation and use of biobanks that store both the material and the related data bears witness to their scientific value, but there is still no consensus— either internationally, or at the European or national levels—about the regulations that should govern biobanks in ethical or legal terms (cambon-thomsen et al, 2007; Kaye, 2005). in particular, consent models designed to appropriately regulate biobankbased research are characterized by a maze of laws, policies and ethical recommendations that range from strict (specific informed consent) to basically unrestricted use (broad consent; Boggio et al, 2007).